Prepare today. For the promises of tomorrow.
At Vantus, we know the incredible potential of veterinary stem cell therapies. We also know there are limited opportunities to acquire the types of cells believed to hold the greatest therapeutic promise.
That is why Vantus is collaborating with the Center for Equine Health and Stem Cell Regenerative Medicine Group at UC Davis’ School of Veterinary Medicine to provide world-leading laboratory services for the collection, processing, clinical return and cryopreservation of veterinary stem cells. Together, we’re developing the advanced processes and technologies so critical to delivering the highest quality therapy.
While the long-term Vantus mission encompasses the full range of veterinary medicine stem cell laboratory services, our initial focus is in the equine arena—collecting and storing stem cells from cell-rich sources including fetal tissue and fluids acquired during foaling, and bone marrow from yearlings. To date, scientific evidence suggests that the equine umbilical cord matrix provides a promising source of high-potential (pluripotent) cells.
1 Adult horse therapies will also be made available using stem cells collected from bone marrow.
Our partnership with the UC Davis School of Veterinary Medicine brings scholars such as
Drs. Gregory Ferraro,
Dori Borjesson, Larry Galuppo, and
Sean Owens directly into the quest for stem cell technologies and processes which will have a significant impact on veterinary medicine. Together with the technological resources of our parent company, ThermoGenesis — a 20-year leader in the processing, preparation, and preservation of cord blood stem cells — with Vantus you’ll have the confidence that comes with choosing the best of all worlds.
Although stem cell therapy is in its infancy, it’s already changing the practice of veterinary medicine. There is widespread agreement that the future will bring continuous breakthroughs and a dramatic new landscape of possibilities.
With Vantus, you can trust your incredibly valuable stem cell resources to the world’s leading scientific minds and proven technologies. Count on our services to help you make the most of today’s opportunities, and give you the peace-of-mind of knowing that when tomorrow’s equine stem cell therapies are ready, you will be too.
Biographies of UCD Collaborators
Gregory L. Ferraro, DVM, has been the Director of the Center for Equine Health at the UC Davis School of Veterinary Medicine since 1998. Prior to his full-time university appointment, he was engaged in private practice, specializing in racing thoroughbred medicine and surgery. Dr. Ferraro is internationally recognized for his knowledge and expertise in equine athletic injuries and has over 35 years of experience in that field. He also served as Clinical Professor of Surgery at UC Davis for many years during and after his private practice career. His interest in advanced therapies for equine injuries stems from years of practical clinical challenges and a scientific thirst for more effective and timely therapeutic interventions.
Dori L. Borjesson, DVM, MPVM, PhD, DACVP, is Associate Professor of Veterinary Clinical Pathology at the UC Davis School of Veterinary Medicine. Dr. Borjesson’s research has focused on bacterial interactions with hematopoietic progenitor cells and mechanisms of bacterial-induced alterations in bone marrow proliferation and differentiation. She has extensive experience working with animal and human cells, including cord blood-derived stem cells, in vivo and in vitro.
Larry Galuppo, DVM, DACVS, is Associate Professor and Chief of Equine Surgery at the UC Davis School of Veterinary Medicine. His clinical expertise is in equine orthopedic surgery, including tendon and ligament injuries and joint disease, with a special interest in traumatology and fracture repair. Dr. Galuppo’s research emphasis is on the biomechanics of fracture generation, implant design and fracture repair, and on novel healing methods for musculoskeletal injuries using regenerative medicine technology.
Sean D. Owens, DVM, MRCVS, DACVP, is Assistant Professor of Clinical Diagnostics/Clinical Pathology at the UC Davis School of Veterinary Medicine. He also directs the UC Davis Animal Blood Bank as well as the Transfusion Medicine Service at the UC Davis Veterinary Medical Teaching Hospital. Dr. Owens’ expertise is in cord blood collection, cord blood processing and cryopreservation of cord blood-derived stem cells. His current research efforts focus on transfusion-related compatibility issues in horses and stem cell transplants and therapies.
References:
1. S.M. Hoynowski et al., Characterization and differentiation of equine umbilical cord-derived matrix cells, Biochem. Biophys. Res. Commun. (2007), doi:10.1016/j.bbrc.2007.07.182